Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Jamf Reports Commencement Of Public Offering Of Its 8.96M Shares Of Common Stock By Investment Funds Affiliated With Vista Equity Partners; Plans Concurrent Stock Repurchase

Author: Benzinga Newsdesk | May 13, 2024 04:45pm

The Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1.04 million shares of Jamf's common stock from the Selling Stockholders.

In addition, Jamf has authorized the purchase from the underwriters of 2 million shares of Jamf's common stock that are the subject of the proposed Offering at the same per share price to be paid by the underwriters to the Selling Stockholders in the Offering 

Posted In: JAMF


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)
CORE Finalist